Cresset Asset Management’s Chimerix, Inc. CMRX Stock Holding History

Cresset Asset Management’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-297	Closed	-$1K	–	1779
2019 Q1	$1K	Buy	+297	New	+$677	﹤0.01%	1902

Other funds holding CMRX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Cresset Asset Management's CMRX Position: Q2 2019 in Review

Cresset Asset Management sold out of Chimerix, Inc. (CMRX) in Q2 2019, closing a stake of 297 shares — an estimated $1K sold.

Cresset Asset Management first reported a position in CMRX in Q1 2019 and held it in 1 quarter. The position peaked at $1K in Q1 2019. 85 funds tracked by Wall St. Rank hold CMRX as of Q2 2019.

Cresset Asset Management reported no remaining Chimerix, Inc. position as of Q2 2019 after selling out during the quarter.
Cresset Asset Management sold 297 Chimerix, Inc. shares in Q2 2019, an estimated $1K.
Cresset Asset Management first reported a position in Chimerix, Inc. in Q1 2019 and held it in 1 quarter.
Cresset Asset Management's Chimerix, Inc. position peaked at $1K in Q1 2019.
85 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2019.

Based on Cresset Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.